4fi7
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4fi7 is ON HOLD | + | The entry 4fi7 is ON HOLD until Paper Publication |
Authors: Connelly, S., Grimster, N., Wilson, I.A., Kelly, J.W. | Authors: Connelly, S., Grimster, N., Wilson, I.A., Kelly, J.W. | ||
Description: Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide | Description: Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide | ||
Revision as of 07:16, 4 July 2012
Unreleased structure
The entry 4fi7 is ON HOLD until Paper Publication
Authors: Connelly, S., Grimster, N., Wilson, I.A., Kelly, J.W.
Description: Kinetic Stabilization of transthyretin through covalent modification of K15 by 3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl)-benzenesulfonamide
